Netherlands· NL-cad9d26a0a5f
Amisulpride ERC 400 mg, filmomhulde tabletten
A sulpiride product containing amisulpride, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Sulpiride is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Sulpiride · ATC N05AL01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sulpiride costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulpiride · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$1.00
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AMISULPRIDE
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- N05AL01
- ATC class
- Sulpiride
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129793//122731
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for sulpiride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulpiride · interactions on record
23 records
23 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sulpiride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAMISULPRIDA APOTEX 400 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGApotex Europe B.V.
- PolandAmisanPRO.MED.CS Praha a.s.
- FranceAMISULPRIDE ARROW 400 mg, comprimé pelliculé sécableARROW GENERIQUES
- BelgiumAlpridemylan 400 mgViatris GX
- CzechiaAMILIAPRO.MED.CS Praha a.s.
- SwitzerlandAmisulpride Zentiva
- IrelandSolian 400 mg film-coated tabletsOriginalis B.V.
- NorwaySolianSanofi-aventis Norge (3)
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Amisu, Solian
- Belgium · Amisulpride Eg, Solian
- Bulgaria · Alonet, Медосулпид
- Cyprus · Aktiprol, Solian
- Czechia · Aktiprol, Amilia
- Germany · Amisulprid Aaa, Amisulprid Mylan
- Denmark · Aktiprol, Amisulprid Dlf
- Estonia · Amisan, Solian
- Spain · Amisulprida Aurovitas, Amisulprida Normon
- France · Amisulpride Arrow Lab, Amisulpride Biogaran
- United Kingdom (Northern Ireland) · Amisulpride, Amisulpride Accord-Uk
- Greece · Isofredil, Nodasic
- Croatia · Aktiprol, Solian
- Hungary · Amisulprid Ratiopharm, Amitrex
- Ireland · Amisulpride Mylan, Solian
- Iceland · Solian
- Italy · Amisulpride Aurobindo, Amisulpride Doc
- Lithuania · Aktiprol, Amisan
- Luxembourg · Amisulpride Eg, Solian
- Latvia · Aktiprol, Solian
- Malta · Aktiprol, Amisulpride Syri Pharma
- Norway · Solian
- Poland · Amipryd, Amisan
- Portugal · Amissulprida Aurobindo, Amissulprida Aurovitas
- Romania · Masultab, Midora
- Slovenia · Solian
- Slovakia · Aktiprol, Amisulprid Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9aa3337c-c321-4591-9c29-c50d4f2044a3 GET /v1/drugs/9aa3337c-c321-4591-9c29-c50d4f2044a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122731_smpc.pdf",
"strength": null,
"atc_label": "Sulpiride",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129793",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"LACTOSE 1-WATER",
"MACROGOLSTEARAAT, TYPE I",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"AMISULPRIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129793.pdf",
"authorised_at": "2022/04/15",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "129793//122731",
"additional_monitoring": "N"
}See everything about sulpiride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.